The OIG has released a report entitled "Comparison of Prices for Negative Pressure Wound Therapy Pumps," which asserts that Medicare is overpaying for NPWT pumps. Among other things, the OIG found Medicare reimbursement for NPWT pumps is more than four times the average price paid by suppliers, which makes pumps “vulnerable to fraud, waste, and abuse." The OIG recommends that CMS use its inherent reasonableness authority to reduce the reimbursement amount for NPWT pumps and include pumps in DMEPOS competitive bidding. CMS also should educate suppliers of new pump models on the importance of communication with beneficiaries’ treating clinicians and follow up on potentially-inappropriate claims. CMS generally concurred with the recommendations.